4//SEC Filing
Sheridan John F 4
Accession 0001628280-25-040844
CIK 0001438133other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 6:14 PM ET
Size
14.0 KB
Accession
0001628280-25-040844
Insider Transaction Report
Form 4
Sheridan John F
EXECUTIVE VP AND COO
Transactions
- Exercise/Conversion
Common Stock
2025-08-15+5,471→ 111,798 total - Tax Payment
Common Stock
2025-08-15$10.82/sh−3,038$32,871→ 111,963 total - Exercise/Conversion
Restricted Stock Unit
2025-08-15−5,471→ 16,415 total→ Common Stock (5,471 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-08-15−5,982→ 41,876 total→ Common Stock (5,982 underlying) - Tax Payment
Common Stock
2025-08-15$10.82/sh−2,779$30,069→ 109,019 total - Exercise/Conversion
Common Stock
2025-08-15+5,982→ 115,001 total
Footnotes (6)
- [F1]Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
- [F2]Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
- [F3]Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
- [F4]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
- [F5]Awarded on May 23, 2024 pursuant to the 2023 Plan, as amended.
- [F6]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
Documents
Issuer
TANDEM DIABETES CARE INC
CIK 0001438133
Entity typeother
Related Parties
1- filerCIK 0001365369
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 6:14 PM ET
- Size
- 14.0 KB